Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA408523
Max Phase: Preclinical
Molecular Formula: C61H108N20O14
Molecular Weight: 1345.66
Molecule Type: Small molecule
Associated Items:
ID: ALA408523
Max Phase: Preclinical
Molecular Formula: C61H108N20O14
Molecular Weight: 1345.66
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCNC(=O)[C@@H](N)CCCN=C(N)N)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O
Standard InChI: InChI=1S/C61H108N20O14/c1-33(2)13-10-11-17-47(84)72-39(18-24-62)55(90)81-49(36(6)83)60(95)77-42(21-27-65)52(87)75-43-23-30-70-59(94)48(35(5)82)80-56(91)44(22-29-69-50(85)38(66)16-12-28-71-61(67)68)76-51(86)40(19-25-63)74-57(92)45(31-34(3)4)78-58(93)46(32-37-14-8-7-9-15-37)79-53(88)41(20-26-64)73-54(43)89/h7-9,14-15,33-36,38-46,48-49,82-83H,10-13,16-32,62-66H2,1-6H3,(H,69,85)(H,70,94)(H,72,84)(H,73,89)(H,74,92)(H,75,87)(H,76,86)(H,77,95)(H,78,93)(H,79,88)(H,80,91)(H,81,90)(H4,67,68,71)/t35-,36-,38+,39+,40+,41+,42+,43+,44+,45+,46-,48+,49+/m1/s1
Standard InChI Key: ZAAXOJZJOZBYCJ-HFENZBBCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1345.66 | Molecular Weight (Monoisotopic): 1344.8354 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Weinstein J, Afonso A, Moss E, Miller GH.. (1998) Selective chemical modifications of polymyxin B., 8 (23): [PMID:9873740] [10.1016/s0960-894x(98)00612-x] |
Source(1):